What's breaking now, across thousands of outlets.
When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences University investigators, was published in Nature Cancer.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
In this edition of STAT Health Tech: Stryker deploys Apple's VR headset Vision Pro for a surgical use case, chatbots for loneliness, and more.
New Trump drug pricing deals, weed edibles and driving research, and more health news from Morning Rounds
Campaigners say some care boards in England flouting their legal duty, resulting in ‘cruel’ postcode lottery Seriously ill children are being denied the chance to die at home because the NHS in many…
Novartis and Bristol Myers Squibb have paused multiple cell therapy trials, while $480,000 has now become a routine price for a cancer drug. Read the latest pharma headlines in today's…
A surgeon clarifies there’s no fixed price for a human kidney, emphasizing compensation over sale. Learn about legal organ donation vs.
Mr Bulus said the deaths were recorded within three days of the outbreak, warning that the number of cases could increase if urgent measures were not taken to contain the disease The post Diphtheria…
